Inventor · disambiguated record
Rajat Varma
Also filed as: VARMA RAJAT
22 granted patents·11 pending applications·103 citations·filing 2017–2024
94Inventor score
Top patents by PatentIndex Score
33 records- 0198US10550185B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragmentsXENCOR INC·Filed 2017·Granted Feb 4, 2020·29 cites·13 claims
- 0298US10501543B2IL15/IL15Rα heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2017·Granted Dec 10, 2019·13 cites·6 claims
- 0396US11358999B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2019·Granted Jun 14, 2022·12 cites·2 claims
- 0495US12509495B2LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domainsXENCOR INC·Filed 2023·Granted Dec 30, 2025·1 cites·5 claims
- 0595US11655277B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2022·Granted May 23, 2023·2 cites·1 claims
- 0695US11505595B2TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domainsXENCOR INC·Filed 2019·Granted Nov 22, 2022·9 cites·12 claims
- 0794US12239688B2IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereofXENCOR INC·Filed 2021·Granted Mar 4, 2025·2 cites·20 claims
- 0894US11851466B2Targeted IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Dec 26, 2023·3 cites·16 claims
- 0994US11319355B2Engineered IL-2 Fc fusion proteinsXENCOR INC·Filed 2018·Granted May 3, 2022·5 cites·5 claims
- 1093US11377477B2PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereofXENCOR INC·Filed 2019·Granted Jul 5, 2022·7 cites·13 claims
- 1192US11084863B2Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domainsXENCOR INC·Filed 2018·Granted Aug 10, 2021·7 cites·16 claims
- 1291US11932675B2PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved propertiesGENENTECH INC·Filed 2020·Granted Mar 19, 2024·2 cites·15 claims
- 1391US11584794B2Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragmentsXENCOR INC·Filed 2019·Granted Feb 21, 2023·2 cites·9 claims
- 1490US11618776B2Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domainsXENCOR INC·Filed 2019·Granted Apr 4, 2023·4 cites·7 claims
- 1590US11524991B2PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereofXENCOR INC·Filed 2019·Granted Dec 13, 2022·5 cites·17 claims
- 1684US2025092108A1ENGINEERED IL-2 Fc FUSION PROTEINSXENCOR INC·Filed 2024·Application pending·0 cites
- 1783US2023220081A1BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTSXENCOR INC·Filed 2022·Application pending·0 cites
- 1883US2025057919A1Il-15/il-15ra heterodimeric fc fusion proteins and uses thereofXENCOR INC·Filed 2024·Application pending·0 cites
- 1980US2022195048A1IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINSXENCOR INC·Filed 2022·Application pending·0 cites
- 2079US12234270B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2022·Granted Feb 25, 2025·0 cites·2 claims
- 2179US11981717B2Engineered IL-2 Fc fusion proteinsXENCOR INC·Filed 2022·Granted May 14, 2024·0 cites·5 claims
- 2277US12448423B2Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domainsXENCOR INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 2377US2020040083A1IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINSXENCOR INC·Filed 2019·Application pending·0 cites
- 2473US12139525B2Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domainsXENCOR INC·Filed 2021·Granted Nov 12, 2024·0 cites·13 claims
- 2573US11859012B2Heterodimeric antibodies that bind CD3 and GPC3XENCOR INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 2673US2024294593A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved propertiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 2772US2024034815A1Heterodimeric antibodies that bind cd3 and gpc3XENCOR INC·Filed 2023·Application pending·0 cites
- 2871US2023331813A1TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINSXENCOR INC·Filed 2022·Application pending·0 cites
- 2968US2023055445A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins and uses in combination therapies thereofXENCOR INC·Filed 2022·Application pending·0 cites
- 3064US2019365861A1Il-15/il-15ra heterodimeric fc fusion proteins and uses thereofXENCOR INC·Filed 2019·Application pending·0 cites
- 3164US2019352362A1LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINSXENCOR INC·Filed 2019·Application pending·0 cites
- 3257US11512122B2IL-7-FC-fusion proteinsXENCOR INC·Filed 2020·Granted Nov 29, 2022·0 cites·9 claims
- 3353US12006345B2Untargeted and targeted IL-10 Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Jun 11, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Rajat Varma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →